Keppra intravenous

When switching from oral KEPPRA, the initial total daily intravenous dosage of KEPPRA should be equivalent to the total daily dosage and frequency of oral KEPPRA. At the end of the intravenous treatment period, the patient may be switched to KEPPRA oral administration at the equivalent daily dosage and frequency of the intravenous administration.

Keppra XRdrugId:1038 (levetiracetam extended-release-Keppra XR)drugId:1038 infusion, intramuscular, intravenous, intravenous piggyback, intravenous push

Keppra (levetiracetam) is indicated in the US: Keppra injection is for intravenous use only as an alternative for patients when oral

The safety profile of levetiracetam is generally similar across age groups (adult and paediatric patients) and across the approved epilepsy indications. Since there was limited exposure for Keppra intravenous use and since oral and intravenous formulations are bioequivalent, the safety information of Keppra intravenous will rely on Keppra oral use.

information for KEPPRA. injection. of KEPPRA injection should be equivalent to those of oral KEPPRA. At the end of the intravenous treatment period, the patient may be switched to . KEPPRA (levetiracetam) injection, for intravenous use . KEPPRA oral administration at the equivalent daily dosage and frequency . Initial U.S. Approval: 2024 (2.4, 2.5)

No data on the interaction of levetiracetam with alcohol are available. 4.6 Keppra intravenous will rely on Keppra oral use. Tabulated list of

bradycardia ( 45) or tachycardia ( 120) -Cardiac contusion -Major Second Line [ ] levETIRAcetam (Keppra) intraVENOUS [ ] Intravenous

Keppra, Keppra Oral Solution, No, Brand, $$$$, No. Keppra, Keppra Intravenous Solution, No, Brand, $$$$, No. Keppra XR, Keppra XR Tablet,Extended Release, No

When switching from oral KEPPRA, the initial total daily intravenous dosage of KEPPRA should be equivalent to the total daily dosage and frequency of oral KEPPRA. At the end of the intravenous treatment period, the patient may be switched to KEPPRA oral administration at the equivalent daily dosage and frequency of the intravenous administration.